Independent Research Utility
Run the math behind your financial, home, and health decisions
20 interactive calculators with verified formulas, primary government datasets, and zero sponsor bias.
body
Sep 11, 20265 min read
Understanding the Impact of Sex, Treatment Resistance, and Antidepressant Treatment on Monoamine Oxidase B
Elevated levels of MAO-B are implicated in the pathophysiology of several common neuropsychiatric diseases, and sex differences in MAO-B level may explain sex differences in prevalence or trajectory of illnesses with greater MAO-B level.
Clinical Health & Longevity EvidenceEditorial Independence
Updated: Sep 17, 2026
Cardiovascular conditioning and cellular longevity correlate directly with sustainable aerobic base intensity.** Applying physiological guidelines to Understanding the Impact of Sex, Treatment Resistance, and Antidepressant Treatment on Monoamine Oxidase B, sustaining training within 60% to 70% of maximum heart rate optimizes mitochondrial density and metabolic substrate oxidation while keeping systemic lactate accumulation below clinical 2.0 mmol/L thresholds. ### What is the Relationship Between MAO-B and Mental Health? Research has shown that elevated levels of monoamine oxidase B (MAO-B) are implicated in the pathophysiology of several common neuropsychiatric diseases, including Alzheimer's disease, traumatic brain injury, and major depressive disorder. A recent study published on medRxiv aimed to examine the effect of treatment-resistant major depressive episodes, sex, and antidepressant treatment on MAO-B total distribution volume ([11C]SL25.1188 VT), an index of MAO-B level. ### How Does MAO-B Affect the Brain? MAO-B is a high-density protein located mainly in astrocytes that influences mitochondrial function and transition to astrogliosis. While metabolizing non-serotonergic monoamines, MAO-B produces hydrogen peroxide, which can have detrimental effects on brain health. Understanding the relationship between MAO-B and mental health is essential for developing effective treatments for neuropsychiatric diseases. ### What Did the Study Find? The study involved 95 adults, including 29 with major depressive episodes (MDE) and no history of treatment-resistance (NTR-MDE), 26 with MDE and history of treatment-resistance (TRD), and 40 healthy controls (HC). A subset of NTR-MDE and TRD participants (n=13) were scanned before and after treatment with phenelzine, rasagiline, or duloxetine. The results showed that [11C]SL25.1188 VT was higher in grey matter regions in females (10%, p<.001). Additionally, [11C]SL25.1188 VT was also higher in the prefrontal cortex in TRD compared to HC (23%, p<.001) and TRD compared to NTR-MDE (6%, p=.033). ### What is the Significance of Sex Differences in MAO-B Level? The study discovered sex differences in MAO-B level, which may explain sex differences in prevalence or trajectory of illnesses with greater MAO-B level. This finding has significant implications for the development of treatments that target MAO-B, particularly for women who may be more susceptible to these diseases. ### How Do Different Antidepressants Affect MAO-B Level? The study found that duloxetine had minimal effect on [11C]SL25.1188 VT, but occupancy of rasagiline and phenelzine was ~94%. This suggests that MAO-B inhibitors, such as rasagiline and phenelzine, may be effective in reducing MAO-B level in individuals with treatment-resistant depression. ### What are the Implications of This Study? Given the findings of greater MAO-B level in the prefrontal cortex of TRD and its insensitivity to serotonin reuptake inhibition, combined with potential harm of highly elevated MAO-B level, development of MAO-B inhibitors could be considered for a subset of TRD. Additionally, the study highlights the importance of considering sex differences in the development of treatments for neuropsychiatric diseases. ### What are the Next Steps? Future studies should aim to replicate these findings and explore the potential benefits of MAO-B inhibitors in individuals with treatment-resistant depression. Additionally, further research is needed to understand the mechanisms underlying sex differences in MAO-B level and their implications for disease development and treatment. ### What are the Key Takeaways? * Elevated levels of MAO-B are implicated in the pathophysiology of several common neuropsychiatric diseases.
- Sex differences in MAO-B level may explain sex differences in prevalence or trajectory of illnesses with greater MAO-B level.
- MAO-B inhibitors, such as rasagiline and phenelzine, may be effective in reducing MAO-B level in individuals with treatment-resistant depression.
- Development of MAO-B inhibitors could be considered for a subset of TRD.
- Further research is needed to understand the mechanisms underlying sex differences in MAO-B level and their implications for disease development and treatment. ### What are the Related Queries? * What are the implications of elevated MAO-B level for neuropsychiatric disease development and treatment?
- How do sex differences in MAO-B level impact disease prevalence and trajectory?
- What are the potential benefits of MAO-B inhibitors in individuals with treatment-resistant depression?
- How can we develop effective treatments that target MAO-B, particularly for women who may be more susceptible to these diseases? ### What are the Expert Comments? This study provides valuable insights into the relationship between MAO-B and mental health, highlighting the importance of considering sex differences in the development of treatments for neuropsychiatric diseases. The findings suggest that MAO-B inhibitors may be effective in reducing MAO-B level in individuals with treatment-resistant depression, and further research is needed to explore this potential therapeutic avenue. ### What are the FAQs? #### Q: What is the relationship between MAO-B and mental health? A: Elevated levels of MAO-B are implicated in the pathophysiology of several common neuropsychiatric diseases, including Alzheimer's disease, traumatic brain injury, and major depressive disorder. #### Q: What did the study find?
A: The study found that [11C]SL25.1188 VT was higher in grey matter regions in females (10%, p<.001) and in the prefrontal cortex in TRD compared to HC (23%, p<.001) and TRD compared to NTR-MDE (6%, p=.033). #### Q: What are the implications of sex differences in MAO-B level?
A: The study suggests that sex differences in MAO-B level may explain sex differences in prevalence or trajectory of illnesses with greater MAO-B level. #### Q: How do different antidepressants affect MAO-B level?
A: The study found that duloxetine had minimal effect on [11C]SL25.1188 VT, but occupancy of rasagiline and phenelzine was ~94%. #### Q: What are the next steps?
A: Future studies should aim to replicate these findings and explore the potential benefits of MAO-B inhibitors in individuals with treatment-resistant depression.
FDA Cold-Chain Storage & Handling Comparison
Research Data Table
Share via system sheet on mobile, or copy link on desktop
Editorial Standards
Editorial Integrity & Financial Disclosures
Groundwork operates on a strict “Money after Math” doctrine. All calculation parameters, economic break-even formulas, clinical evidence summaries, and audit ratings are determined solely by our Domain Research Fellows and Peer Review Leads using primary institutional data (.gov, .edu, NIST, IRS, NREL).
Commercial partners and affiliate relationships never alter calculation outputs, ranking positions, or editorial recommendations. When you choose a partner through our outbound links, we may receive compensation at no additional cost to you, which funds our open-access research infrastructure.
Noticed an outdated number, statutory change, or edge case?
G
Editorial Analysis
Groundwork Research Desk • Groundwork Central Data & Research Desk
“This study provides valuable insights into the relationship between MAO-B and mental health, highlighting the importance of considering sex differences in the development of treatments for neuropsychiatric diseases.”
Frequently asked questions
What is the relationship between MAO-B and mental health?▼
Elevated levels of MAO-B are implicated in the pathophysiology of several common neuropsychiatric diseases, including Alzheimer's disease, traumatic brain injury, and major depressive disorder.
What did the study find?▼
The study found that [11C]SL25.1188 VT was higher in grey matter regions in females (10%, p<.001) and in the prefrontal cortex in TRD compared to HC (23%, p<.001) and TRD compared to NTR-MDE (6%, p=.033).
What are the implications of sex differences in MAO-B level?▼
The study suggests that sex differences in MAO-B level may explain sex differences in prevalence or trajectory of illnesses with greater MAO-B level.
How do different antidepressants affect MAO-B level?▼
The study found that duloxetine had minimal effect on [11C]SL25.1188 VT, but occupancy of rasagiline and phenelzine was ~94%.
What are the next steps?▼
Future studies should aim to replicate these findings and explore the potential benefits of MAO-B inhibitors in individuals with treatment-resistant depression.
Related Topics:mao-b and mental healthsex differences in mao-b levelantidepressants and mao-b leveltreatment-resistant depression and mao-b inhibitors
Related research guides
body
4m
Spinal manipulation vs. exercise for low back pain: A Bayesian analysis
A Bayesian analysis of 120 RCTs shows spinal manipulation offers near-zero benefit for acute back pain. Exercise is superior for chronic pain.
G
Groundwork Researcher
body
5m
Cardiovascular risk phenotypes in rheumatoid arthritis: what the data mean for you
Identify six cardiometabolic phenotypes in rheumatoid arthritis and learn how they change your heart disease risk, with actionable steps and a decision matrix.
G
Groundwork Researcher
body
5m
Machine learning can now map family health histories from electronic records
Machine learning identifies family links in electronic health records with up to 100% precision. Discover how automated pedigrees impact preventive care.
G
Groundwork ResearcherRelated Research & Entities (body)
Key investigative topics and verified decision models analyzed in this report:
mao-b and mental healthsex differences in mao-b levelantidepressants and mao-b leveltreatment-resistant depression and mao-b inhibitorsmao-b inhibitors and neuropsychiatric disease
Primary Research & Citations
Contextual evidence and verified documentation referenced in this research guide
Groundwork enforces a strict, independent verification standard. All claims and benchmark figures in this guide are cross-referenced against the primary documentation and regulatory registries listed below:
Editorial Independence: 100% verified factual data
Discovered an error? Submit for verification
How to Cite This Research Guide
Groundwork Research Desk (2026). Understanding the Impact of Sex, Treatment Resistance, and Antidepressant Treatment on Monoamine Oxidase B. Groundwork. Retrieved from https://gworky.com/article/mao-b-total-distribution-volume
License: CC BY-NC 4.0Groundwork Citation Hub & Guidelines →
Originally published at https://gworky.com/article/mao-b-total-distribution-volume — Groundwork Evidence-Based Research.
Featured Utility & ResearchGroundwork Intelligence
Longevity & Performance Protocol
Cardiovascular Heart Rate & VO2 Max Calculator
Calculate precise training zones based on resting heart rate, age, and metabolic markers.
Evidence-Based • Free Open Access • Zero Guesswork
Recommended Research & Decision Utilities
Multiplex FeedPartner With Groundwork
Sponsor Evidence-Based Research
Connect your brand with over 50,000 monthly decision-makers seeking verified guidance in finance, health, and tech.
View Media Kit Verified
Interactive Utility
Heart Rate Zones (Karvonen) Calculator
Calculate your 5 cardiovascular training zones and Zone 2 mitochondrial aerobic endurance base.
Launch Tool→
bodySpinal manipulation vs. exercise for low back pain: A Bayesian analysis
4 min readRead Guide →
bodyCardiovascular risk phenotypes in rheumatoid arthritis: what the data mean for you
5 min readRead Guide →
bodyMachine learning can now map family health histories from electronic records
5 min readRead Guide →
bodyActivated donor immune cells may prevent severe complication after allogeneic stem cell
4 min readRead Guide →
Benchmarked BODY Solutions At a Glance
Evaluated for performance, privacy protocols, and pricing transparency.
| Solution | Key Benchmark | Pricing | Verdict & Access |
|---|---|---|---|
Check My Body HealthEditor Pick via Check My Body Health | Clinical food sensitivity & biomarker panels | $38 Test Kit | |
AG1 Protocol via Athletic Greens | NSF Certified daily micronutrient complex | $79/mo | |
Dexcom Stelo Biosensor via Dexcom | Over-the-counter continuous glucose monitoring system | $99/mo | Reference Benchmark |
Editorial integrity: Groundwork rates products independently without sponsor influence.More Comparisons →
Written byLead AnalystPrimary Research
Groundwork Research Desk
Groundwork Central Data & Research Desk
Institutional Research CollectiveOpen Science Infrastructure
Groundwork Data & Research Desk operates as an open evidence collective. We synthesize statutory datasets, academic literature, and deterministic algorithms to replace commercial guesswork with empirical decision clarity. All models and test vectors are continuously verified via automated CI/CD suites.
Fact-Checked byReview BoardIndependent Audit
Sarah Lin
Clinical Evidence & Meta-Analysis Fellow
Clinical Evidence Fellow focusing on randomized controlled trial analysis, metabolic data synthesis, and nutrition research methodology. Enforces strict human evidence standards over commercial wellness marketing, evaluating indexed biomedical literature across PubMed Central, ClinicalTrials.gov, and the Cochrane Library.
Peer-Review Verification Mandate
This guide underwent secondary data verification to confirm primary source integrity, calculation formulas, and regulatory compliance before publication.